MétaCan
Menu
← Back to cohort
Record W2146670786 · doi:10.1183/09031936.06.00024505

Epidemiology and costs of chronic obstructive pulmonary disease

2005· review· en· W2146670786 on OpenAlexaffabout
K.R. Chapman, David M. Mannino, Joan B. Soriano, P. Vermeire, A. Sonia Buist, Michael J. Thun, Carol Connell, Ahmedin Jemal, Todd A. Lee, Marc Miravitlles, Sarah Aldington, Richard Beasley

Bibliographic record

VenueEuropean Respiratory Journal · 2005
Typereview
Languageen
FieldMedicine
TopicChronic Obstructive Pulmonary Disease (COPD) Research
Canadian institutionsUniversity Health Network
FundersGlaxoSmithKline
KeywordsMedicineCOPDEpidemiologyPulmonary diseasePresentation (obstetrics)ReputationNatural historyFamily medicineDisease burdenObstructive lung diseasePublic relationsGerontologyDiseaseMedical educationPolitical sciencePathologySurgeryLawPsychiatry

Abstract

fetched live from OpenAlex

Worldwide, COPD is in the spotlight, since the high prevalence, morbidity and mortality present challenges for healthcare systems.The inconsistent use of terminology for COPD, and the lack of widely accepted diagnostic standards for the diseases that are included in the coding within the COPD spectrum have contributed to the inaccuracy of mortality data for COPD.The approach of using the single term COPD (rather than individual coding for chronic bronchitis, emphysema and chronic airway obstruction) is being championed in global and national guidelines, with the expectation that this will improve awareness, simplify the coding and, ultimately, lead to greater accuracy in death certification for COPD.In 2000, there were more deaths in the USA from COPD among females than males.In contrast to the trend for cardiovascular diseases, death rates from COPD have been rising steadily over the past few decades.This striking increase in COPD as a cause of death is projected to occur because of the worldwide epidemic of smoking, and the changing global demographics where more people in developing countries are living longer and, therefore, are at risk of COPD for longer.Prevalence estimates may vary widely depending on which spirometric criteria are used.The BOLD initiative, which is a programme designed to provide strictly standardised, rigorous and practical methods for estimating the prevalence and social and economic burden of COPD, is described. GLOBAL ECONOMIC COSTS AND MODELLING IN COPD SummaryIn addition to understanding the epidemiology of a disease, estimates of the disease costs are important for appreciating the overall disease burden.Estimates of the economic burden of a disease are important for informing policy decisions.Health economic models can be used to estimate the future burden of disease or to understand the value of an intervention.Importantly, the cost estimates of the components of a disease are vital for developing health economic models of diseases.The focus of this section of the paper is to review the economic burden of COPD and COPD disease-state models.Published cost estimates from Spain, Sweden, the USA, the Netherlands and Italy are reviewed.Additional attention is given to the cost of exacerbations, which is an important component of the overall cost of COPD.Finally, the use of health-state models in COPD is briefly discussed and the BOLD study model is introduced.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.016
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.014
Threshold uncertainty score0.028

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.016
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0020.004
Science and technology studies0.0000.001
Scholarly communication0.0020.002
Open science0.0000.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.079
GPT teacher head0.376
Teacher spread0.297 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations708
Published2005
Admission routes2
Has abstractyes

Explore more

Same venueEuropean Respiratory Journal→Same topicChronic Obstructive Pulmonary Disease (COPD) Research→French-language works237,207→